Chemed revises 2025 EPS guidance to $22–$22.30, signals no significant 2026 Medicare cap in Florida Chemed revises 2025 EPS guidance to $22–$22.30, signals no significant 2026 Medicare cap in Florida Post ContentcheRead More You might also be interested in reading Sberbank Issues First Crypto Backed Loan in Russia. July 30, 2025 In Mainstream ← Previous post Next post →